8 minute read

Developing thoughts

PRACTICE MATTERS

Developing thoughts

This month, Phil Mullins looks at the benefits and logistics of going fully private

Are you ready to go private?

Since the moment that the universal NHS eye examination was removed, and Margaret Thatcher said that a private eye exam would cost around £10, the optical profession has been fighting for the NHS to pay a fair and reasonable fee for general ophthalmic services. Obviously, we have not been helped by elements of our profession giving their services away for free, but what is the alternative?

During the Covid-19 pandemic, there have been a growing number of voices contemplating going totally private, particularly as the NHS has been painfully slow in responding to our profession or recognising the importance of frontline optometry and the part it plays in the nation’s overall health. This has forced many to look at those practices that only deal with private patients, and wonder whether this represents the future for independents in the UK.

DO YOUR HOMEWORK However, before plunging headlong into changing your entire business model, you need to consider certain issues – and whether you can overcome them. The first big question is: do you really want to see only private patients? Do you really want to cut off a complete section of your community? Of course, some over 60s are happy to pay for private care, but many can’t afford it. And what about children? This is before you look at families, many of whom may have lost their income during the pandemic. Are you going to leave these patients to the multiples?

Secondly, do you have enough private patients currently to survive? Although you will attract new patients, you will rely heavily on your current patient base – at least initially. Your average annual patient spend will be higher, but you will be seeing fewer patients. This calculation has changed post lockdown, with many practices seeing far fewer patients; however, the conversion rate is very much higher and, in many cases, average dispensing values are up too. This may not continue as the world returns to normal, but it does show that fewer patients can still work as a business model.

The next step is to get a real grip of your costs, so you can calculate what to charge. Bear in mind that you may have to extend your examination time and possibly invest in higher grade equipment if you are charging higher private fees. Once you have calculated how much to charge, and how many patients you will need to see, look at how you will collect the fees. Will it be pay as you go, or via payment plans? Will you spread payments over a period with a third party, such as Eyeplan or Iris Vision Care, or via your own direct debit system?

Only having done the due diligence outlined above should you look to go totally private. If you do head in that direction, make sure you consider staff training, marketing, and how to communicate your plans with your existing patients. What will you do about the children of your private patients? Will you alter frame prices? And most importantly: do you have a plan B?

SOFTLY, SOFTLY APPROACH But why go totally private? Why not wean yourself off your NHS reliance, and move a larger proportion of patients to private elements of your business? Having a form of payment plan is essential as it enables you to increase income, add loyalty and differentiate from the NHS offering. It also enables you to build private services such as dry eye, glaucoma and diabetic monitoring, myopia control lenses for children, and ortho-k for vision correction.

If you’re thinking about locking out NHS patients: be prepared

All of the above are private services, which can be charged at a correct level without having to discount a single pair of spectacles. When you sign up patients to a fees plan covering their eye examinations, make sure that it offers value. Include fundus image or optical coherence tomography, annual examinations, and extended payment options for spectacles. And if you want to, lower prices on the spectacles themselves. You will also need to consider how to handle NHS upgrades. Do you simply take what you can claim off the total, or do you promote an upgrade price? It might end up being the same financially, but it’s how you promote it to patients that is important.

As you can see, there are many things to consider regarding going private. I do believe that the future of the independent market is towards the private end of the market, but it will be alongside a mix of NHS patients, with either full or partial NHS funding, which will enable you to offer your clinical care to the wider elements of your community. In the meantime, let’s hope that the NHS will see sense and begin to recognise the importance of eyecare and increase the funding, which will help the whole profession and industry.

At the forefront of visionary innovations in eye care for over 167 years

INNOVATIVE SCLERALS

18mm small scleral and 20/23mm full scleral lenses MAXIM (multi-curve design) Spherical, toric, multifocal, toric multifocal and bi-focal QUANTUM (unique spheric / aspheric design) Spherical and multifocal Our mission is simple, yet powerful: Helping your patients see better,

to live better with our comprehensive eye care portfolio.

As optical experts, we value our crucial relationship with Independent

Opticians and the support you provide to patients, which is why we

work hard to understand patients’ needs to incorporate them into our

ongoing development of technologically advanced contact lens and

Bausch + Lomb has become a global hallmark for innovation and quality

High quality gas permeable lenses: Bausch + Lomb is also one of the world leaders in the research, development and supply of gas permeable contact lenses. So if you’re looking for high-quality, bespoke RGP lenses for your patients and professional clinical support, choose Bausch + Lomb. As well as aiming to dispatch orders in 48 hours, all our RGP lenses are guaranteed on a warranty exchange programme – ensuring your patients will receive the very best products, fast.

FULL SCLERALS

REGULAR CORNEA

lens care products, as well as innovative materials.

IRREGULAR CORNEA

MAXIM CV (small scleral design) Spherical, toric and multifocal ZENLENS™ (small scleral design) Prolate and oblate designs with smart curve technology QUANTUM K (corneal keratoconic bespoke design) For corneas exhibiting signs of nipple and oval keratoconus and some cases of pellucid marginal degeneration

Made to order lenses Delivered in 48 hours

Technical Support Bespoke and expert advice Professional Affairs Training and support Warranty Exchange Programme On all RGP lenses: 180 days on scleral lenses; 90 days on corneal lenses

Our technical support team are on hand to help with expert advice and orders. Get in touch today: N 0870 850 7921 E rgpsupport@bausch.com

The lens with the Most Moisture 1

hours of moisture 2 †

78 %

water content 1

98 %

moisture retention 2 †

uv blocking 3**

NEW PARAMETERS

The ONLY daily toric with a –2.75D cyl MORE parameters than any other toric daily disposable lens 4 *

2538 PARAMETERS

Now available for more of your patients

NOW IN CYLINDER -2.75

Cylinders

AXES

LOW MINUS POWER

10° 20° 30° 40° 50° 60° 70° 80° 90° 100° 110° 120° 130° 140° 150° 160° 170°

180° **-2.75 cylinder in 0.50 steps 97% Your peers reported rotation of 10 o or less on 97% of patients at dispensing 5 0.00D to -6.00D (in 0.25D steps)

HIGH MINUS POWER 96% of patients indicated that their overall opinion of

Biotrue ® ONEday for

Astigmatism was good to excellent 6 -6.50D to -9.00D (in 0.50D steps) +0.25D to +4.00D (in 0.25D steps)

-0.75 -2.75 ** -1.25 -1.75 -2.25 -2.25-0.75 -1.25 -1.75 -2.25-0.75 -1.25 -1.75

Range October 2019 New in 2020

Was 1528 SKUs (Oct ‘19), now 2538 SKUs, +66%

PLUS POWER

98%

Your peers were satisfied with the speed of fitting on 98% of patients 5

Order your trial lenses today: N 0845 602 2350 E cs.vc.uk@bausch.com

NEW NEW FitBetter app Makes fitting toric and multifocal lenses even easier. Just put in a prescription and the app helps calculate the recommended toric and multifocal trial lens for your patients. Download from Apple Store or on Google Play.

COMING SOON IN 2020

Biotrue ® multipurpose solution: makes wearing contact lenses easier on your patients’ eyes

Delivers proven disinfection 1

• A dual disinfection system contains an optimal combination of two disinfectants 2

Unsurpassed disinfection efficacy 1

Delivers continuous patient comfort 3

An innovative protein management system to maintain natural tear protein function 4

Advanced formulation contains the wetting agent hyaluronan for continuous patient comfort 3

Biotrue ® multi-purpose solution: offers patient convenience when cleaning

Supports business growth with enhanced customer loyalty

Increases the likelihood of contact lens patient satisfaction 5 as a clean lens means a comfortable lens

In a study, 9 out of 10 who considered stopping lens wear significantly reduced their likelihood of dropping out of contact lens wear after using Biotrue ® multi-purpose solution for just 2 weeks 5

ORDER YOUR FREE STARTER KITS TODAY

As our modern lifestyles become increasingly busy, offer your patients the convenient way to clean their contact lenses with Biotrue ® multipurpose solution with just a 4 hour soak time to achieve clean lenses. 2

Supporting business growth with enhanced customer loyalty

Order your free starter kits today: N 0845 602 2350 E cs.vc.uk@bausch.com

1. David, B., et al. Evaluation of multipurpose solutions for in vitro biocidal efficacy against a challenge of ocular clinical isolates including methicillin-resistant staphylococcus aureus and methicillin-resistant staphylococcus epidermidis strains. Rochester. 2. Biotrue® multi-purpose solution package insert. 3. Millward Brown., 2010. Biotrue® Product Test (#640). 4. Wright, E. A., et al., 2012. Preservation of human tear protein structure and function by a novel contact lens multipurpose solution containing protein-stabilising agents. Eye & Contact Lens, 38(1), pp. 36-42. 5. Rah, M., et al., 2014. Reducing dropout of contact lens wear with Biotrue® multipurpose solution. Clinical Ophthalmology, 8, pp. 293-299

This article is from: